|
Palm Oil Protects Your Brain
Study shows tocotrienols in palm oil
protect brain cells
In a study published in the prestigious
Journal of Biological Chemistry (April 2000), researchers at the
University of California, Berkeley found that tocotrienols, especially
alpha-tocotrienol, protects glutamate-induced death of neuronal cells
(brain cells). This study also provided the first evidence describing
the molecular basis of tocotrienol action. Tocotrienols are a special,
super potent form of vitamin E found in palm oil.
There are two types of vitamin E. Tocopherol is
the type we are most familiar with. Tocotrienol is the less common form
that is found in abundance in palm oil. Each form of vitamin E has four
subgroups designated by alpha, beta, gamma, and delta. Alpha-tocopherol
is the most common form of vitamin E. It is the form we see in vitamin
supplements and fortified foods. Alpha-tocotrienol is the most abundant
form of vitamin E in palm oil. Researchers have found that alpha-tocotrienol
from palm oil has up to 60 times the antioxidant activity as alpha-tocopherol.
Oxidative damage due to free radicals or
reactive oxygen species has been implicated in age-related
neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and
Huntington’s. In the pathogenesis of these diseases, oxidative damage
may accumulate over a period of years, leading to massive neuronal loss.
A major contributor to pathologic cell death within the nervous system
is glutamate toxicity and appears to be mediated by reactive oxygen
species. The induction of oxidative stress by excitatory amino acid such
as glutamate has been demonstrated to be the primary cause of death of
certain types of neuronal cells. Glutamate is used by researchers to
induce neurological damage in lab studies. We get glutamate in our diet
from monosodium glutamate (MSG), “natural flavoring” added to foods, and
soy products, to mention a few.
In the study it was found that at low
concentrations of tocotrienols were more effective than alpha-tocopherol
(the common form of vitamin E) in preventing glutamate-induced brain
cell death. At higher concentrations, the glutamate-induced neuronal
cells not only recovered after 6 hours of glutamate treatment, the
tocotrienols, and especially alpha-tocotrienol, provided complete
protection against further loss of cell viability.
It was also interesting to note that among the
tocotrienols (alpha and gamma fractions), the alpha-tocotrienol was more
effective than gamma-tocotrienol in protecting the neuronal cells.
The researchers went on to study the protective
effect of the free-form and esterified-form of alpha-tocotrienol in
glutamate-induced death of neuronal cells. It was found that the
free-form was preferentially absorbed by the cells and due to this
preferential uptake of the free-form tocotrienol, it confers higher
protection against glutamate-induced death of brain cells.
In order to explain the neuroprotective
property of tocotrienols, the researchers looked at the involvement of
signal transduction pathways in the glutamate-induced cell death.
Studies have shown that inhibitors of protein-tyrosine kinase activity
completely prevented glutamate-induced cell death. It was evident from
the study that tocotrienols inhibited the activation of c-Src tyrosine
kinase activity. Inhibition of c-Src kinase activity has significant
implications and may explain other protective properties of tocotrienols.
For example, studies have shown that many intracellular pathways can be
stimulated upon Src activation and a variety of cellular consequences
can result, including morphological and cell proliferation. One of them
is human breast cancer. Increased in Src tyrosine kinase activity has
been implicated in the progression of breast cancer. Mammary tumors and
human skin tumors possess elevated c-Src tyrosine kinase activity.
Because of the key involvement of Src kinase activity in various
oncogenesis, inhibitors of these kinases are being studied as potential
candidates for anti-cancer drugs. Tocotrienols with their ability to
inhibit the activation of Src kinase activity holds potential as natural
complimentary phytonutrient in preventing these cancers. However, more
studies need to be carried out to confirm this effect.
In summary, this enlightening study
demonstrated that naturally occurring tocotrienols especially alpha-tocotrienol
may be an effective natural phytonutrient in preventing age-related
neurodegenerative disease and certain type of c-Src kinase-mediated
cancers. Palm oil has the highest level of alpha-tocotrienol. Even
though the study was carried out in cultured neuronal cells, it
nevertheless showed promising results in the protection of these cells.
There are several possible interpretations of this study. Some
scientists think that we need actual human trials to confirm the effect
of tocotrienols in preventing age-related neurodegenerative diseases
such as Alzheimer’s and Parkinson’s. Previous studies have shown that
the ordinary form of vitamin E (tocopherols) confer protection against
Alzheimer’s disease. Tocotrienol from palm oil has shown to be even
better at protecting neuronal cells. While it is important to get
clinical studies, it is unreasonable for those people who could benefit,
to wait for 5 or 10 years for the results of studies, when they can do
something right now. The evidence from this study and many other studies
is good enough to start using palm oil to take advantage of its
protective tocotrienols. There is no compelling reason not to.
For further information and
studies showing the neuroprotective and anticancer effects of palm oil
read The Palm Oil Miracle by Dr. Bruce Fife, available at
www.piccadillybooks.com or
www.amazon.com.
This website is for informational purposes only, and is educational in
nature. Statements made here have not been evaluated by the FDA. Nothing
stated on this website is intended to diagnose, treat, cure or prevent
any disease.
Copyright © Coconut Research Center, 2004 |